<DOC>
	<DOC>NCT02940366</DOC>
	<brief_summary>This purpose of this study is to evaluate effect of high-dose Pitavastatin on glucose control in patients with metabolic syndrome.</brief_summary>
	<brief_title>Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Patients diagnosed as metabolic syndrome according to National cholesterol Education Program criteria Patients with hypercholesterolemia who required to start statin therapy overt diabetes acute coronary syndrome within 2 months acute cerebrovascular event within 2 months recent treatment of statin within 1month recent diagnosed neoplasm recent diagnosed liver disease chronic kidney disease patients with myopathy pregnant women, nursing mothers, women with possibility of pregnant patients being adminstered cyclosporine patients with genetic disease such as galactose intolerance, lactose intolerance, glucosegalactose malabsorption patients with treatment cyclosporin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>